मंगलवार, 8 जनवरी 2019

thumbnail

Lupin's myotonia treatment drug gets European Commission's approval

The approval makes NaMuscla the first treatment to be licensed throughout the EU for the symptomatic treatment of myotonia in adults with NOM disorders

from Latest News http://bit.ly/2CUDgfA

Related Posts :

Subscribe by Email

Follow Updates Articles from This Blog via Email

No Comments

About

ब्लॉग आर्काइव

Blogger द्वारा संचालित.